Collagenous colitis and atezolizumab therapy: an atypical case

Immune checkpoint inhibitors such as anti-CTLA-4 (cytotoxic T-lymphocyte-associated protein 4), anti-PD-1 (programmed cell death protein 1), and PD-L1 (programmed cell death protein-ligand 1) are emerging drugs that have radically changed treatment and prognosis of different types of tumors. However...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallo, Antonella, Talerico, Rosa, Novello, Luca, Giustiniani, Maria Cristina, D’Argento, Ettore, Bria, Emilio, Montalto, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886711/
https://www.ncbi.nlm.nih.gov/pubmed/33151423
http://dx.doi.org/10.1007/s12328-020-01276-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886711/
https://www.ncbi.nlm.nih.gov/pubmed/33151423
http://dx.doi.org/10.1007/s12328-020-01276-4

Ejemplares similares